Published in J Adolesc Young Adult Oncol on December 17, 2015
Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Prefer Adherence (2017) 0.78
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 42.90
Adherence to medication. N Engl J Med (2005) 39.77
Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care (1986) 22.65
Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res (1999) 9.85
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med (2010) 5.17
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol (2009) 3.63
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA (1992) 3.06
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer. J Clin Oncol (2004) 3.03
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat (2012) 3.02
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer (2008) 2.63
Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat (2006) 2.55
Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol (1993) 2.43
Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol (2001) 2.36
The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst (2005) 1.92
Association of breast cancer and its therapy with menopause-related symptoms. Menopause (2004) 1.81
Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care (2007) 1.80
Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns (2005) 1.61
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat (2010) 1.40
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer (2013) 1.36
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. Am J Surg (2008) 1.28
Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial. Cancer Prev Res (Phila) (2011) 1.19
Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed? Eur J Cancer (2012) 1.02
Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Res Treat (2014) 1.02
Longitudinal predictors of nonadherence to maintenance of mammography. Cancer Epidemiol Biomarkers Prev (2010) 1.01
A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians. Breast Cancer Res Treat (2013) 0.98